Janssen Pharmaceuticals, a unit of Johnson & Johnson ($JNJ), has submitted a new drug application to the FDA for a 500-milligram chewable tablet targeting intestinal ...

Impax announced that the Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for Emverm (mebendazole) chewable tablets. Impax announced that the Food and ...

has approved Vermox chewable (mebendazole chewable 500mg tablets) for the treatment of patients one year of age and older with gastrointestinal infections caused by Ascaris lumbricoides (roundworm) ...